National Health Research Institutes, Taiwan: Carcinoma trials

The registry lists 13 Carcinoma studies with National Health Research Institutes, Taiwan as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 7Phase 3 5No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• BI-754091 and Afatinib for Refractory Esophageal Squamous Cell Carcinoma (BEAR Study)CompletedNCT04839471Phase 2
• Pembrolizumab for Nasopharyngeal Carcinoma Patients With Detectable Plasma Epstein-Barr Virus DNATerminatedNCT03544099Phase 2
• Nivolumab Plus Ipilimumab as Neoadjuvant Therapy for Hepatocellular Carcinoma (HCC)CompletedNCT03510871Phase 2
• Phase II Study to Evaluate the Efficacy and Safety of TLC388 for Differentiated Neuroendocrine Carcinomas PatientsCompletedNCT02457273Phase 2
• Study of Sorafenib With Combination of Thalidomide in Hepatocellular Carcinoma (HCC)TerminatedNCT00971126Phase 1/2
• A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell CarcinomaCompletedNCT00933387Phase 2
• A Phase III Study in Post-operative HBV-related Hepatocellular CarcinomaTerminatedNCT00455091
• Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT00390195Phase 1/2
• A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal CarcinomaCompletedNCT00201396Phase 3
• Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma PatientsCompletedNCT00201383Phase 3
• A Phase III Study of Radiotherapy With or Without Adjuvant C/T in Advanced Stage Nasopharyngeal Carcinoma PatientsTerminatedNCT00201344Phase 3
• Chemoprevention Study of Oral Cavity Squamous Cell CarcinomaCompletedNCT00201279Phase 3
• Phase Ⅲ Randomized Trial in Postoperative Hepatocellular CarcinomaCompletedNCT00149565Phase 3